ECNP: European College of Neuropsychopharmacology
Conference Coverage
Lag in antidepressant treatment response explained?
Compared with the placebo group, participants taking escitalopram had a marked increase in synaptic density.
Conference Coverage
Smart bracelet may predict mood changes in bipolar disorder
Each sensor collects a sample every second, resulting in highly detailed and granular data.
Conference Coverage
Running vs. meds for depression: Is there a clear winner?
Medication “generally had worse impact on body weight, heart rate variability, and blood pressure, whereas running therapy led to improved effect...
Conference Coverage
Major depression treatments boost brain connectivity
“This is the thing everyone is looking for when we’re talking about a biomarker: That we see this exact pattern” – and it is why they are so...
Latest News
Nicotine blocks estrogen production in women’s brains
There is evidence to suggest that there is a complex interaction between sex and steroid hormones and the reward effect of nicotine, modulated by...
Conference Coverage
Healthy diet, less news helped prevent anxiety, depression during COVID
The study “provides some important insights as to which behaviors may protect our mental health during times of significant stress.”
Conference Coverage
Cognition-boosting ‘smart drugs’ not so smart for healthy people
“While the drugs administered were motivational, the resulting increase in effort came at a cost in the loss of productivity.”
Conference Coverage
‘Amazing’ phase 3 results for novel schizophrenia combo drug
This agent is “really revolutionary in the field. It’s a non-dopamine compound which helps for schizophrenia, so we’re all very optimistic about...
Conference Coverage
Bipolar risk and parental age: What’s the relationship?
“We must stress that this risk is moderate, and it must be kept in perspective,” said Dr. Giovanna Fico.
Conference Coverage
Antiepileptic medications linked to increased priapism risk
If clinicians encounter such cases of priapism, they should be “reported to the regulatory authorities,” said lead researcher Dr. Ana Pejcic.
Conference Coverage
Art therapy linked to slowed Parkinson’s progression
The positive effect of art therapy could be related to “activating the brain’s reward neural network,” said Dr. Iryna Khubetova.
Conference Coverage
‘Impressive’ results for novel antidepressant, so why the FDA delay?
Results showed the drug had a clinical response rate of 80% and a remission rate of almost 70%.
Conference Coverage
Lower thyroid hormone levels a red flag for elevated suicide risk?
Patients with suicidal ideation were 54% less likely to have higher TSH levels.
Conference Coverage
Steroid a promising short-term treatment option for major depression?
“These data continue to support the development of zuranolone as a potential 14-day short course treatment” for MDD episodes, said Dr. Colville...
Conference Coverage
Inattention to heightened CV risk common theme in clozapine deaths teaser
“Inadequate treatment for metabolic syndrome was found to be a mortality predictor while on clozapine therapy,” said Dr. Sharon Taub.